What is the current valuation of the Japan biobanking market in 2024?

The market valuation was $2261.79 Million in 2024. Read More

What is the projected market valuation for the Japan biobanking market by 2035?

The projected valuation for 2035 is $3526.0 Million. Read More

What is the expected CAGR for the Japan biobanking market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 4.12%. Read More

What are the main sample types in the Japan biobanking market and their valuations?

Sample types include Blood Products ($500.0 - $800.0 Million), Tissues ($400.0 - $600.0 Million), and Nucleic Acids ($600.0 - $900.0 Million). Read More

How does the application segment of the Japan biobanking market perform?

The application segment includes Research and Development ($904.72 - $1390.0 Million) and Clinical Trials ($681.34 - $1050.0 Million). Read More

What are the end-use segments in the Japan biobanking market?

End-use segments include Academic Research Institutions, Biotechnology Companies, and Pharmaceutical Companies, each valued at $2261.79 - $3526.0 Million. Read More

What storage types are utilized in the Japan biobanking market?

Storage types include Vapor Phase Storage ($500.0 - $800.0 Million) and Cryopreservation Storage ($961.79 - $1526.0 Million). Read More

What trends are observed in the growth of the Japan biobanking market?

The market appears to be growing steadily, with a projected increase in valuation from $2261.79 Million in 2024 to $3526.0 Million by 2035. Read More

How do the key players influence the Japan biobanking market?

Key players like Illumina and Merck KGaA likely drive innovation and market growth through advanced technologies and strategic partnerships. Read More

Japan Biobanking Market

Q: Which companies are considered key players in the Japan biobanking market?

Key players include Thermo Fisher Scientific, Qiagen, Illumina, Merck KGaA, and ReproCELL. Read More

ID: MRFR/HC/52634-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

Japan Biobanking Market Research Report: Size, Share, Trend Analysis By Sample Type (Blood Products, Tissues, Cells, Nucleic Acids, Microbiome Samples), By Applications (Research and Development, Clinical Trials, Personalized Medicine, Regenerative Medicine), By End Use (Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Government Organizations) and By Storage Type (Vapor Phase Storage, Liquid Phase Storage, Cryopreservation Storage) - Growth Outlook & Industry Forecast 2025 To 2035

Japan Biobanking Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.12%

2024 Market Size$ 2,261.79 Million

2025 Market Size$ 2,354.98 Million

2035 Market Size$ 3,526 Million

Key Players

Thermo Fisher Scientific

Qiagen

Illumina

Merck KGaA

STEMCELL Technologies

BioLife Sciences

Trends

Technological Advancements
Regulatory Support
Focus on Personalized Medicine

Opportunities

Rising Demand for Biobanking Services
Technological Integration and Automation
Growing Public Awareness and Participation

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Sample Type (USD Million)
  1. 4.1.1 Blood Products
  2. 4.1.2 Tissues
  3. 4.1.3 Cells
  4. 4.1.4 Nucleic Acids
  5. 4.1.5 Microbiome Samples
2. 4.2 Medical Device, BY Application (USD Million)
  1. 4.2.1 Research and Development
  2. 4.2.2 Clinical Trials
  3. 4.2.3 Personalized Medicine
  4. 4.2.4 Regenerative Medicine
3. 4.3 Medical Device, BY End-use (USD Million)
  1. 4.3.1 Academic Research Institutions
  2. 4.3.2 Biotechnology Companies
  3. 4.3.3 Pharmaceutical Companies
  4. 4.3.4 Government Organizations
4. 4.4 Medical Device, BY Storage Type (USD Million)
  1. 4.4.1 Vapor Phase Storage
  2. 4.4.2 Liquid Phase Storage
  3. 4.4.3 Cryopreservation Storage
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Qiagen (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Illumina (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Merck KGaA (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 STEMCELL Technologies (CA)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 BioLife Sciences (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 ReproCELL (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Biobanking Solutions (NL)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Global Biobank (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 JAPAN MARKET ANALYSIS BY SAMPLE TYPE
3. 6.3 JAPAN MARKET ANALYSIS BY APPLICATION
4. 6.4 JAPAN MARKET ANALYSIS BY END-USE
5. 6.5 JAPAN MARKET ANALYSIS BY STORAGE TYPE
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY SAMPLE TYPE, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY SAMPLE TYPE, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY END-USE, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY END-USE, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY STORAGE TYPE, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY STORAGE TYPE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SAMPLE TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USE, 2025-2035 (USD Million)
  4. 7.2.4 BY STORAGE TYPE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Japan Medical Device Market Segmentation

Medical Device By Sample Type (USD Million, 2025-2035)

Blood Products
Tissues
Cells
Nucleic Acids
Microbiome Samples

Medical Device By Application (USD Million, 2025-2035)

Research and Development
Clinical Trials
Personalized Medicine
Regenerative Medicine

Medical Device By End-use (USD Million, 2025-2035)

Academic Research Institutions
Biotechnology Companies
Pharmaceutical Companies
Government Organizations

Medical Device By Storage Type (USD Million, 2025-2035)

Vapor Phase Storage
Liquid Phase Storage
Cryopreservation Storage

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”